BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) is a publicly traded Healthcare sector company. As of July 16, 2026, BRTX trades at $0.35 with a market cap of $8.66M and a P/E ratio of -0.21. BRTX moved +8.79% today. Year to date, BRTX is -70.14%; over the trailing twelve months it is -77.94%. Its 52-week range spans $0.16 to $2.55. Rallies surfaces BRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BRTX moved +8.79% today.
| Metric | Value |
|---|---|
| Price | $0.35 |
| Market Cap | $8.66M |
| P/E Ratio | -0.21 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.55 |
| 52-Week Low | $0.16 |
| Volume | 589.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $359.70K |
| Net Income | $-14.24M |
| Gross Margin | 93.37% |
BRTX analyst coverage data. Average price target: $0.00.